ACADIA PHARMACEUTICALS INC (ACAD)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch ACAD
See up to 3 months of ACAD. The 7-day demo opens the 1M and 3M ranges and puts ACAD on your watchlist.
Start 7-day demoLatest ACAD insider trades
About ACADIA PHARMACEUTICALS INC (ACAD)
The SEC lists ACADIA PHARMACEUTICALS INC under CIK 0001070494, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ACAD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 36,699 | $1.02M |
| Option exercise | 6 | 104,826 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ACAD insider transactions (Form 4)
10553 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 5,849 | $17.84 | $104K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 5,849 | $29.00 footnote F3 | $170K | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 14,292 | $17.84 | $255K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 5,000 | $29.00 | $145K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 9,292 | $29.34 | $273K | |
| Mark C. Schneyer - Officer | Option exercise | Stock Option (Right to Buy) | 5,849 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Stock Option (Right to Buy) | 14,292 | $0.00 | - | |
| ||||||
| Elizabeth H.Z. Thompson - Officer | Option exercise | Common Stock | 32,272 | - footnote F1 | - | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 16,508 | $26.13 | $431K | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 50 | $26.17 | $1K | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Restricted Stock Units | 32,272 | $0.00 | - | |
| ||||||
| James Kihara - Officer | Open-market sale | Common Stock | 11,421 | $26.08 footnote F2 | $298K | |
| ||||||
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 18,622 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 18,622 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 32,008 footnote F11 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 32,008 footnote F11 | $0.00 | - | |
| ||||||
| Edmund Harrigan | Option exercise | Common Stock | 8,107 | - footnote F1 | - | |
| Edmund Harrigan | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Edmund Harrigan | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Edmund Harrigan | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| ||||||
| Adora Ndu | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| Adora Ndu | Option exercise | Common Stock | 8,107 | - footnote F1 | - | |
| Adora Ndu | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Adora Ndu | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| ||||||
| Laura Brege | Option exercise | Common Stock | 8,107 | - footnote F1 | - | |
| Laura Brege | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Laura Brege | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Laura Brege | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| ||||||
| Jonathan Poole | Option exercise | Common Stock | 2,010 | - footnote F1 | - | |
| Jonathan Poole | Option exercise | Restricted Stock Units | 2,010 | $0.00 | - | |
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| ||||||
| Elizabeth A. Garofalo | Option exercise | Common Stock | 8,107 | - footnote F1 | - | |
| Elizabeth A. Garofalo | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Elizabeth A. Garofalo | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Elizabeth A. Garofalo | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| ||||||
| James M. Daly | Option exercise | Common Stock | 8,107 | - footnote F1 | - | |
| James M. Daly | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| James M. Daly | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| James M. Daly | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| ||||||
| James Kihara - Officer | Open-market sale | Common Stock | 5,401 | $21.18 footnote F1 | $114K | |
| ||||||
| James Kihara - Officer | Option exercise | Common Stock | 2,596 | - footnote F1 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,332 | $21.79 footnote F3 | $29K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,596 | $0.00 | - | |
| ||||||
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 6,815 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 3,506 | $21.79 footnote F3 | $76K | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 6,815 | $0.00 | - | |
| ||||||
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 5,276 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 2,709 | $22.20 | $60K | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 5,276 | $0.00 | - | |
| ||||||
| James Kihara - Officer | Option exercise | Common Stock | 2,010 | - footnote F1 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,030 | $22.20 footnote F3 | $23K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,010 | $0.00 | - | |
| ||||||
| Adams Catherine Owen - Officer | Option exercise | Common Stock | 23,509 | $0.00 footnote F1 | - | |
| Adams Catherine Owen - Officer | Open-market sale | Common Stock | 11,641 | $21.47 | $250K | |
| Adams Catherine Owen - Officer | Option exercise | Restricted Stock Units | 23,509 | $0.00 | - | |
| ||||||
| Jennifer J. Rhodes - Officer | Option exercise | Common Stock | 7,515 | $0.00 footnote F1 | - | |
| Jennifer J. Rhodes - Officer | Open-market sale | Common Stock | 3,844 | $21.47 | $83K | |
| Jennifer J. Rhodes - Officer | Option exercise | Restricted Stock Units | 7,515 | $0.00 | - | |
| ||||||
| Elizabeth H.Z. Thompson - Officer | Option exercise | Common Stock | 6,715 | - footnote F1 | - | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 3,435 | $21.47 | $74K | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Restricted Stock Units | 6,715 | $0.00 | - | |
| ||||||
| James Kihara - Officer | Option exercise | Common Stock | 1,627 | - footnote F1 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 833 | $21.47 | $18K | |
| James Kihara - Officer | Option exercise | Common Stock | 2,142 | - footnote F1 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,097 | $21.65 | $24K | |
| James Kihara - Officer | Open-market sale | Common Stock | 12 | $21.73 | $261 | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 1,627 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,142 | $0.00 | - | |
| ||||||
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 8,138 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 4,177 | $21.47 | $90K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 3,171 | $21.65 | $69K | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 6,178 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 37 | $21.72 | $804 | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 8,138 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 6,178 | $0.00 | - | |
| ||||||
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 7,482 | $0.00 | - | |
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 3,565 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 4,218 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 2,010 | $0.00 | - | |
| James Kihara - Officer | Grant or award | Restricted Stock Units | 6,332 | $0.00 | - | |
| James Kihara - Officer | Grant or award | Stock Option (Right to Buy) | 21,766 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Grant or award | Stock Option (Right to Buy) | 90,691 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Grant or award | Restricted Stock Units | 26,382 | $0.00 | - | |
| Mark C. Schneyer - Officer | Grant or award | Restricted Stock Units | 26,382 | $0.00 | - | |
| Mark C. Schneyer - Officer | Grant or award | Stock Option (Right to Buy) | 90,691 | $0.00 | - | |
| Thomas Garner - Officer | Grant or award | Restricted Stock Units | 28,493 | $0.00 | - | |
| Thomas Garner - Officer | Grant or award | Stock Option (Right to Buy) | 97,947 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Grant or award | Stock Option (Right to Buy) | 101,574 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Grant or award | Restricted Stock Units | 29,548 | $0.00 | - | |
| Adams Catherine Owen - Officer | Grant or award | Stock Option (Right to Buy) | 263,005 | $0.00 | - | |
| Adams Catherine Owen - Officer | Grant or award | Restricted Stock Units | 76,509 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Option exercise | Common Stock | 12,944 | $0.00 footnote F1 | - | |
| Jennifer J. Rhodes - Officer | Open-market sale | Common Stock | 6,950 | $23.38 footnote F4 | $162K | |
| Jennifer J. Rhodes - Officer | Option exercise | Restricted Stock Units | 12,944 | $0.00 | - | |
| ||||||
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 9,913 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 9,913 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 9,913 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 9,913 | - footnote F1 | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 10,262 | $23.69 footnote F4 | $243K | |
| ||||||
| James Kihara - Officer | Option exercise | Restricted Stock Units | 3,966 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Common Stock | 3,966 | - footnote F1 | - | |
| James Kihara - Officer | Option exercise | Common Stock | 3,966 | - footnote F1 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 4,084 | $23.69 footnote F4 | $97K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 3,966 | $0.00 | - | |
| ||||||
Item 7.01, 8.01, 9.01
Item 8.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Recent ACAD Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Schneyer Mark C. | Officer | 5,849 | $159K | View on EDGAR | |
| - | - | - | - |
ACAD insider trading FAQ
What is the latest insider trade for ACAD?
ACADIA PHARMACEUTICALS INC (ACAD) had 2 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for ACAD runs to 53 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACAD stock?
No insider purchases of ACAD were filed in the last 90 days.
How many insiders are selling ACAD stock?
5 insider sales of ACAD were filed in the last 90 days, totaling $1.02M.
Where can I see ACAD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACAD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark C. Schneyer view on EDGAR
- - Elizabeth H.Z. Thompson view on EDGAR
- - James Kihara view on EDGAR
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Edmund Harrigan view on EDGAR
- - Adora Ndu view on EDGAR
- - Laura Brege view on EDGAR
- - Jonathan Poole view on EDGAR
- - Elizabeth A. Garofalo view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ACAD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACAD with a 7-day demo
- ACAD on your watchlist
- Every ACAD Form 4 filing on record
- Up to 3 months of ACAD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
